• Cost Savings in the Hungarian Care Managing Programme

    Nov 1, 2013, 00:00

  • A Comparative Study on the Cost of Antibiotics for the Years 2011-2012 in Three General Hospitals of Greece

    Nov 1, 2013, 00:00

  • Correlation Between Prognostic Factors and Non Prosthetic Further Fracture Related Treatment After Femoral Neck Fracture Underwent Internal Fixation in Elderly

    Nov 1, 2013, 00:00

  • From “Generic Scheme” to “Brand-Generic Scheme”- The Effect of New Policy (2003-2004) on Efficiency of Iranian Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por Atonía Uterina En Pacientes Con Factores De Riesgo En Colombia

    Nov 1, 2013, 00:00

  • Different Discounting Approaches and Their Impact in Economic Evaluation- A Practical Example Using Hepatitis B Vaccination

    Nov 1, 2013, 00:00

  • Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 Countries

    Nov 1, 2013, 00:00

  • Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective- A Retrospective Analysis of the Orizon Database

    Nov 1, 2013, 00:00

  • Comparing Copd Costs By Exacerbation Frequency and Dyspnoea Level in a Primary Care Setting in the United Kingdom

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Concomitant Aortic Valve Replacements in France and the United Kingdom

    Nov 1, 2013, 00:00

  • Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • The Affordability of Oncology and HIV/AIDS Technologies in Brazil Compared to the United States and Other OECD Countries

    Nov 1, 2013, 00:00

  • User and Treatment Characteristics of Oral Contraceptives in the European Union

    Nov 1, 2013, 00:00

  • Economic Evaluation of Liraglutide for Treatment of Type 2 Diabetes Mellitus in the Russian Federation

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Liraglutide Versus Sitagliptin in Type 2 Diabetes in the United Kingdom- A Retrospective Study in Primary Care

    Nov 1, 2013, 00:00

  • Construcción De Un Modelo De Priorización Aplicable a Latinoamérica – El Caso De Colombia

    Nov 1, 2013, 00:00

  • Análise Custo-Minimização (ACM) Do Cloridrato De Valganciclovir Comparado Com Ganciclovir Na Profilaxia Da Infecção Por CMV Em Transplantados Renais

    Nov 1, 2013, 00:00

  • The Association Between European Medicines Agency Approval and Health Technology Assessment Recommendation

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Cognitive-Behavioral Therapy for Major Depressive Disorder – A Systematic Review

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Intravenous Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Russia

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis in Iran

    Nov 1, 2013, 00:00

  • Calidad De Prescripción De Antibióticos En El Servicio De Pediatria De Un Hospital General De Cardenas, Tabasco, México

    Nov 1, 2013, 00:00

  • Impact of Switching on Health Care Costs and Outcomes in Generic Drug Policies

    Nov 1, 2013, 00:00

  • Retrospective Analysis of Oncology Indications Utilizing Drug Expenditures from 2005 to 2012 in the Republic of Srpska

    Nov 1, 2013, 00:00

  • The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical Modelling

    Nov 1, 2013, 00:00

  • A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Assessing the Future Burden of Renal Replacement Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Japanese Representation in Leading General Medicine and Basic Science Journals- A Comparison of Two Decades

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Ioxaglato Versus Iodixanol En Angiografía Coronaria

    Nov 1, 2013, 00:00

  • EQ-5D-5L Crosswalk Value Set for Poland

    Nov 1, 2013, 00:00

  • Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology- A Willingness-To-Participate Study

    Nov 1, 2013, 00:00

  • Trends in Chemotherapy Setting and Costs from 2005 to 2012- A Case Study Using Bevacizumab

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma

    Nov 1, 2013, 00:00

  • Systematic Review of Patient Reported Outcomes in Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • The Cost of Producing a Unit of Blood in Hospitals- A Nationwide Economic Analysis for the Case of Greece

    Nov 1, 2013, 00:00

  • Evaluation of the Potential Efficacy of Ivabradine in Health Care of the Republic of Belarus

    Nov 1, 2013, 00:00

  • Correlation Between Montgomery-Asberg Depression Rating Scale (MADRS) and the Beck Depression Inventory II (BDI-II) in Patients with Focal Epilepsy

    Nov 1, 2013, 00:00

  • Health Care Costs Associated with Chronic Hepatitis C Infection in Europe

    Nov 1, 2013, 00:00

  • Factorial Invariance of the Whoqol-Old Across Gender, Age, and Resident Area in Taiwan

    Nov 1, 2013, 00:00

  • Addressing Childhood-Obesity in Mexico- Savings on Health Care Expenditures from Regulating Food and Beverage Sales in Basic Education Schools

    Nov 1, 2013, 00:00

  • Benefits of Vildagliptin Plus Metformin Combination Therapy in Type 2 Diabetes Mellitus (T2DM) from Patient’s Perspective- Quality of Life (QoL) and Hypoglycemia Burden Analysis

    Nov 1, 2013, 00:00

  • Calibration of a Cost-Effectiveness Model to Evaluate the Incorporation of a Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Argentina- Disease Burden Component

    Nov 1, 2013, 00:00

  • Uptake of Denosumab in the Treatment of Osteoporosis in the Czech Republic

    Nov 1, 2013, 00:00

  • Analysis and Classification of Risk-Sharing Schemes Proposed in Reimbursement Application Received by AHTAPol in 2012

    Nov 1, 2013, 00:00

  • Therapy Escalation Thresholds and the Potential for Biased Cost Effectiveness Analysis When Failing to Sample Baseline HbA1c in Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Consumption Patterns, Market Characteristics and Regulation in the Pharmaceutical Industry- Evidence from Two Therapeutic Groups in Insured Population in Argentina

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Schizophrenia

    Nov 1, 2013, 00:00

  • Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom

    Nov 1, 2013, 00:00

  • Chemotherapy Treatment Patterns, Health Care Costs, and Mortality of Lung Cancer Patients in Taiwan – A Longitudinal Study Between 2000 and 2008

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico

    Nov 1, 2013, 00:00

  • Economic Impact of a Smoking Cessation Program in Mexico- Enrolling Employees and Employers

    Nov 1, 2013, 00:00

  • Do EMA and FDA Have Different Opinions/Requirements in Terms of Pediatric Studies for Sitagliptin (Alone or in Combination)?

    Nov 1, 2013, 00:00

  • Pre-Financing Function of the Pharmaceutical Full-Line Wholesale Sector in the European Union

    Nov 1, 2013, 00:00

  • What Are the Clinical and Economic Costs and Benefits of Implementing Point of Care Tests for Chlamydia Trachomatis and Neisseria Gonorrhoea in Genito-Urinary Medicine Clinics in the United Kingdom?

    Nov 1, 2013, 00:00

  • The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

    Nov 1, 2013, 00:00

  • The Nice Medical Technology Evaluation Programme (MTEP) – Insights for Manufacturers Considering Notification

    Nov 1, 2013, 00:00

  • Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB)

    Nov 1, 2013, 00:00

  • Incorporating Stakeholder Input into Budget Impact Models to Compare Stem Cell Mobilization Strategies

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fluoroquinolone-Based Regimens for the Treatment of Community-Acquired Pneumonia in a Multi-Field Hospital in Russia

    Nov 1, 2013, 00:00

  • Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security Institution

    Nov 1, 2013, 00:00

  • Attitudes of Physicians Toward Implementing Shared Medical Appointments at National Guard Family Medicine Centers in Riyadh

    Nov 1, 2013, 00:00

  • An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies

    Nov 1, 2013, 00:00

  • ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT- RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients with Prostate Cancer in the United States

    Nov 1, 2013, 00:00

  • A Non-Interventional Retrospective Evaluation of Resources Consumed During the Provision of Care for Overactive Bladder Syndrome- A Real World Evaluation- German Perspective (The Reduce Study)

    Nov 1, 2013, 00:00

  • A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)

    Nov 1, 2013, 00:00

  • Societal Unmet Needs in Brazil- Examining Prevalence, Treatment Rates, and Health Outcomes

    Nov 1, 2013, 00:00

  • Impact of Value Communication in Decision Making- An Approach to the Treatment of Type 2 Diabetes in Portugal

    Nov 1, 2013, 00:00

  • Safety in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Gastroesophageal Reflux Disease in Slovakia

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in Greece

    Nov 1, 2013, 00:00

  • Cost-Utility of Rheumatoid Arthritis Monotherapy with Tocilizumab in Spain

    Nov 1, 2013, 00:00

  • Revised Scoring of the WPAI-Hep C Improves Assessment of Missed Work and Work Impairment in HCV Clinical Trials

    Nov 1, 2013, 00:00

  • Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone- A Cost-Effectiveness Analysis from the Perspective of the Italian Health System

    Nov 1, 2013, 00:00

  • Additional Clinical Benefit for Patient Relevant Endpoints- Investment Disincentives by AMNOG in the Example of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • The Efficacy of the Extra Front Loading Smoking Cessation Counselling Sessions on the Abstinence Rate Compared with Usual Care Used in Quit Smoking Clinic in Penang, Malaysia

    Nov 1, 2013, 00:00

  • Relationship Between Medication Adherence and Quality of Life in COPD – Systematic Review

    Nov 1, 2013, 00:00

  • Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

    Nov 1, 2013, 00:00

  • A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar Brasileiro

    Nov 1, 2013, 00:00

  • Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento Cardiovascular

    Nov 1, 2013, 00:00

  • Quantifying Health Care Efficiency- A Review of Published Time and Motion Study Design Parameters Referenced in Pubmed Between 2008-2013

    Nov 1, 2013, 00:00

  • Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory

    Nov 1, 2013, 00:00

  • A Lei De Acesso À Informação Fortalece O Papel Da Avaliação De Tecnologias Em Saúde (ATS) De Fornecer Informações Sólidas E Transparentes Aos Usuários Do Sistema Único De Saúde

    Nov 1, 2013, 00:00

  • Patient Networks as a Data Source for Patient Reported Outcomes Research. Carenity Experience

    Nov 1, 2013, 00:00

  • Household Feeding Practices for the Sick Under Five Children; Gucha South District-Kisii County, Kenya

    Nov 1, 2013, 00:00

  • Review of Nice Technology Appraisals in Oncology- How Does Clinical Evidence Change Over Time?

    Nov 1, 2013, 00:00

  • Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Colágena-Polivinilpirrolidona En El Tratamiento De Osteartrosis De Rodilla I-Ii Frente Al Cuidado Estandar Establecido En Los Protocolos Vigentes De Las Instituciones Publicas En México

    Nov 1, 2013, 00:00

  • Current Situation of Oral Anticancer Treatments Use in Fran The Actor Study (Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • Evaluating Willingness-To-Pay Threshold for Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade- A Contingent Valuation Survey

    Nov 1, 2013, 00:00

  • Changes in Patient-Reported Outcomes Among Pediatric Leukemia and Lymphoma Patients During the First 2-Years Post Allogeneic Stem Cell Transplantation (alloSCT)

    Nov 1, 2013, 00:00

  • Analysing the Access to Priority Health Services in the Adolescent Population in Six Provinces in Northern Argentina

    Nov 1, 2013, 00:00

  • Pharmacotherapeutic Monitoring of Patients Using Immunobiological in a Health Insurance Company in Brazil- To Know to Better Manage

    Nov 1, 2013, 00:00

  • Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab- Model Based Analysis

    Nov 1, 2013, 00:00

  • Screen or Not to Screen for Peripheral Arterial Disease- Guidance from a Decision Model

    Nov 1, 2013, 00:00

  • Patient Eligibility and Use of Biologics in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in the United States

    Nov 1, 2013, 00:00

  • Revisión De Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • Budget Impact of Metastatic Castrate-Resistant Prostate Cancer (CRPC) to German Payers

    Nov 1, 2013, 00:00

  • A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses in Borderline Personality Disorder

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Infant Pneumococcal Vaccination in the Netherlands

    Nov 1, 2013, 00:00

  • Utilizing Storytelling to Promote Rational Antibiotic Use in 9-11 Years Old School Children in Iran

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Chronic Kidney Disease in the United States

    Nov 1, 2013, 00:00

  • Prevention of Gram-Positive Infections in Peritoneal Dialysis Patients – A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Profile of Back Pain Sufferers Across 5EU Countries

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ioversol Versus Iohexol for Diagnostic Procedures

    Nov 1, 2013, 00:00

  • Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States

    Nov 1, 2013, 00:00

  • Troika in Portugal- Pharmaceutical Sector from Paper to Reality

    Nov 1, 2013, 00:00

  • Reducing the Length of Antibiotic Prophylaxis in Clinical Conditions

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

    Nov 1, 2013, 00:00

  • Diferencias En La Consecución De Información Sobre Costos Del Manejo De La Diabetes Mellitus En Colombia

    Nov 1, 2013, 00:00

  • Burden of Infusion-Related Costs and Staff Time for Rheumatoid Arthritis in the Hospital Setting

    Nov 1, 2013, 00:00

  • Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population

    Nov 1, 2013, 00:00

  • Costs of Primary Biliary Cirrhosis Treatment with Ursodeoxycholic Acid in Brazil

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

    Nov 1, 2013, 00:00

  • Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United States

    Nov 1, 2013, 00:00

  • Loss of Productivity in Polish Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Drug Reimbursement in Germany

    Nov 1, 2013, 00:00

  • Self-Monitoring of Blood Glucose with Insulin Analogues- Nice to Have or Need to Have? Analysis of Phase III Registration Trials and European Public Assessment Reports of Insulin Analogues

    Nov 1, 2013, 00:00

  • Costs Comparison of Cutaneous Drug Reactions Treatment Divided by Diagnosis Groups

    Nov 1, 2013, 00:00

  • Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall- A Systematic Review

    Nov 1, 2013, 00:00

  • Economic Evaluations of Varicella and Herpes Zoster Vaccination Programmes- A Systematic Review

    Nov 1, 2013, 00:00

  • Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012

    Nov 1, 2013, 00:00

  • Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context

    Nov 1, 2013, 00:00

  • The Future of Individual Funding Requests in Clinical Commissioning Groups Era

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Agomelatine in Depressed Thai Patients Including the Elderly Depressed Population

    Nov 1, 2013, 00:00

  • Epidemiology for Oncological Drugs Regarding the Benefit Dossier Preparation in Germany

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

    Nov 1, 2013, 00:00

  • Treatment Patterns and Burden of Illness of Acromegaly in the United Kingdom- Real World (RW) Data from Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA)

    Nov 1, 2013, 00:00

  • Resource Use of Non-Small Cell Lung Cancer in Slovakia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal Perspective

    Nov 1, 2013, 00:00

  • Price Differences Triggered by the Availability of Biosimilars in Developed Countries

    Nov 1, 2013, 00:00

  • A Cost-Consequence Analysis of Different Protease Inhibitors Schemes for HIV Treatment from the Colombian Health Care System Perspective

    Nov 1, 2013, 00:00

  • Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cobas® EGFR Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic NSCLC- A Payer Perspective in the United Kingdom

    Nov 1, 2013, 00:00

  • EVPI Curves in Practice

    Nov 1, 2013, 00:00

  • Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating Tuberculosis

    Nov 1, 2013, 00:00

  • Economic Evaluation of Mandibular Advancement Device to Treat Obstructive Sleep Apnea

    Nov 1, 2013, 00:00

  • Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 Mcg for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

    Nov 1, 2013, 00:00

  • Argentina’s Generic Drug Law- Was It Successful?

    Nov 1, 2013, 00:00

  • Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil

    Nov 1, 2013, 00:00

  • Toxocariasis- A Disease of High Prevalence But Forgotten

    Nov 1, 2013, 00:00

  • Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden

    Nov 1, 2013, 00:00

  • Adherence to Antiretroviral Therapy Among HIV-Infected Patients Attending to a University Infectious Diseases Clinic in Venezuela

    Nov 1, 2013, 00:00

  • Assessing the Fiscal Consequences of Immunizing the Female and Male Population Against Human Papillomavirus (HPV) in Germany

    Nov 1, 2013, 00:00

  • Managed Entry Agreements and Orphan Drugs- A European Comparative Study (2006-2012)

    Nov 1, 2013, 00:00

  • Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS)- Operational Setup for a Multi-Country, Multi-Center Study

    Nov 1, 2013, 00:00

  • Value Judgments in Health Technology Assessment Process in Brazil

    Nov 1, 2013, 00:00

  • Short-Term Disability (STD) Associated with Skeletal Related Events (SRES) in Commercially Insured Patients with Bone Metastases (BM) Secondary to Solid Tumors

    Nov 1, 2013, 00:00

  • Comprehensive Overview- Efficacy, Tolerability and Cost- Effectiveness of Irbesartan

    Nov 1, 2013, 00:00

  • Issues with Cost-Effectiveness Modelling of Diagnostic Tests – Case Study of Ischaemic Cardiomyopathy

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus a DPP-4 Inhibitor in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

    Nov 1, 2013, 00:00

  • Systematic Review- The Economic Burden of Crohn’s Disease in Europe in Adults and Children

    Nov 1, 2013, 00:00

  • Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis- Results from the Open-Label Extension Study of Rapi ...

    Nov 1, 2013, 00:00

  • Two-Way Sensitivity Analysis- Showing the Impact of Correlated Parameters in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess the Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU)

    Nov 1, 2013, 00:00

  • Resource Use and Disease Progression Among HCV-Positive Patients

    Nov 1, 2013, 00:00

  • Poder Popular Y Regulación Del Precio De Los Medicamentos En Venezuela

    Nov 1, 2013, 00:00

  • Benefit of Adding Panitumumab to FOLFOX4 in Patients with KRAS/NRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC)- A Number-Needed-To-Treat (NNT) Analysis

    Nov 1, 2013, 00:00

  • Two Simple Methods of Measuring Adherence in Hypertensive Patients Are Predictive of Blood Pressure Control- Pooled Analysis of 17,516 Patients from Seven Valsartan Studies

    Nov 1, 2013, 00:00

  • Developing a Population-Based Dementia Registry Focusing on Patients and Carer Needs- Methodological Challenges

    Nov 1, 2013, 00:00

  • Orphan Drugs in the German Early Benefit Assessment– Real World Versus G-Ba Bureaucracy

    Nov 1, 2013, 00:00

  • Validity of QOL Impact Attributions to Specific Diseases- A Multitrait-Multimethod Comparison

    Nov 1, 2013, 00:00

  • Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil- Results from a 12-Month Retrospective Analysis of an Administrative Database

    Nov 1, 2013, 00:00

  • Investigating the Impact of Mental Health Status on Health and Social Care Costs of Older People after Acute Hospital Admission

    Nov 1, 2013, 00:00

  • The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric Validation of a New Patient Reported Outcome Measure

    Nov 1, 2013, 00:00

  • Length of Stay and Outcomes for Adolescents Treated for Substance Use Disorder- An Analysis of Dose Respose Using Propensity Scores

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life (HRQL) in Chronic Hepatitis C (CH-C) Patients Treated with Sofosbuvir Containing Interferon-Free Regimens

    Nov 1, 2013, 00:00

  • Hepatitis a Vaccine Policy Process in 6 Countries – Factors Influencing Potential Adoption

    Nov 1, 2013, 00:00

  • Hemangioma Family Burden- Creation of a Specific Questionnaire

    Nov 1, 2013, 00:00

  • The Estimated Survival of Patients with Double Refractory Chronic Lymphocytic Leukaemia; A Reanalysis of NICE TA202 Using Bayesian Methodology to Model Observed Data

    Nov 1, 2013, 00:00

  • Use of the French Claims and Hospitalisations Database to Estimate the Prevalence and Incidence of Parkinson’s Disease in France

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Patient Preferences and Priorities for Anti-Epileptic Drug Treatment

    Nov 1, 2013, 00:00

  • WITHDRAWN

    Nov 1, 2013, 00:00

  • Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D

    Nov 1, 2013, 00:00

  • Improvements in Physical Function, Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis Treated with Golimumab- Sub-Analysis of Latin American Patients Enrolled in Mulitcentre Phase III Clinical Trials

    Nov 1, 2013, 00:00

  • Impacto De La Diabetes Sobre La Productividad En Argentina

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Del Uso De Estatinas En La Prevención De Eventos Cardiovasculares En Colombia

    Nov 1, 2013, 00:00

  • Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings- An Individual Patient Data Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Trasplante Renal Comparado Con La Diálisis En Colombia

    Nov 1, 2013, 00:00

  • A Parent-Administered But Child-Completed Patient-Reported Outcome (PRO) Provides a Measure with Content Validity That Is Valid and Reliable for Use in Children Aged 6 to 11 Years

    Nov 1, 2013, 00:00

  • Characteristics of Children and Adolescents Using Proton Pump Inhibitors or Histamine-2-Receptor Antagonists- Analysis of Thin and Pharmo Databases

    Nov 1, 2013, 00:00

  • Costos Económicos Asociados A Secuelas De Meningitis En Colombia

    Nov 1, 2013, 00:00

  • Perception of Users of Drug Distribution Program in Brazil

    Nov 1, 2013, 00:00

  • Parental Preferences for Rotavirus Vaccination and Potential Vaccination Coveragein Young Children- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC)- Mean Overall Survival (OS) in a “Better Responders” Patient Population of the Velour Trial

    Nov 1, 2013, 00:00

  • Markov Models in Non Metastatic Prostate Cancer – Availability of Input Factors and Structurural Uncertainty

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Detemir in T2DM Patients Poorly Controlled with NPH Insulin in Poland

    Nov 1, 2013, 00:00

  • Análisis Costo-Utilidad De Dos Alternativas Para El Tratamiento De Bebés Prematuros En Bogotá

    Nov 1, 2013, 00:00

  • Re-Engineering of the Distribution of Drugs in the Hospital. TOC Application and TRZ

    Nov 1, 2013, 00:00

  • Eliciting the Relative Importance of Key Elements for Benefit-Risk Assessment- A Comparison Among General Population, Health Authority and Medical Doctors

    Nov 1, 2013, 00:00

  • Efficacy of Long-Acting Injectable Antipsychotic Therapies in Maintenance Treatment of Schizophrenia- A Mixed Treatment Comparison (MTC) of Double-Blind Randomized Clinical Trials

    Nov 1, 2013, 00:00

  • Mapping the Oxford Hip Score (OHS) to EQ-5D- A Test of Model Performance

    Nov 1, 2013, 00:00

  • Efficacy and Tolerability of CT-Guided Epidural Steroid Injections and Pharmacotherapy for Managing Chronic Low Back Ache with Radiculopathy

    Nov 1, 2013, 00:00

  • Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T)

    Nov 1, 2013, 00:00

  • A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular Disease

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of a New Fixed-Dose Combination Inhaler for a Clinical Commissioning Group within the National Health Service in England

    Nov 1, 2013, 00:00

  • Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012

    Nov 1, 2013, 00:00

  • Increased Risk of Cancer Incidence Associated with Repeat Medical Imaging- Designing Better Clinical Trial Protocols

    Nov 1, 2013, 00:00

  • Clinical Benefits of Immunosuppression Therapy in Renal Trasplant Patients. Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Paliperidone Palmitate in National Health Service (NHS) Wales- A Cost Utility Analysis Based on the National Institute for Health and Care Excellence (NICE) Core Model for the Management of Schizophrenia

    Nov 1, 2013, 00:00

  • A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30) - Cuban Group of Trialists on Epidermal Growth Factor (CGT-EGF)

    Nov 1, 2013, 00:00

  • Análisis Economico De La Profilaxis Secundaria Versus El Tratamiento a Demanda De Una Cohorte De Pacientes Colombianos Con Hemofilia a Y B Severa

    Nov 1, 2013, 00:00

  • Scoring the Center for Epidemiologic Studies – Depression Scale- Which Items Go Where?

    Nov 1, 2013, 00:00

  • Assessing Measurement Equivalence of Different Forms of Administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) Using Rasch Analysis

    Nov 1, 2013, 00:00

  • How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?

    Nov 1, 2013, 00:00

  • Naturalistic Disease Management Study of Patients with Alcohol Dependence in the Primary Care Setting in the United Kingdom (STREAM)

    Nov 1, 2013, 00:00

  • A Comparison of German Benefit Assessments by G-Ba, IQWiG and Manufacturers

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Tres Estrategias Diagnosticas Para La Identificación De Infección Bacteriana Severa En Lactantes Febriles Sin Foco

    Nov 1, 2013, 00:00

  • Predicting Health Care Costs in Asthma Using the EQ-5D Index Score

    Nov 1, 2013, 00:00

  • The Effectiveness of Statins in the Treatment of Cardiovascular Disease- Cross-Sectional Study with Paired Groups from Electronic Patient Records

    Nov 1, 2013, 00:00

  • Persistence Patterns with Oral Hypoglycaemic Medicines (OHM) in Newly Treated Irish Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Electrical Impedance Spectroscopy (EIS) Device Used as an Adjunct to Colposcopy

    Nov 1, 2013, 00:00

  • What Value Can Operational Feasibility Studies Bring to Post Marketing Observational Studies (PMOS)? Example of Feasibility Study Performed in Eastern Europe to Assess Hepatitis C Viral Disease/Patient Management in Real World Setting

    Nov 1, 2013, 00:00

  • The Influence of HAQ Utility Mapping Algorithms on the Cost-Effectiveness of Second Line Biologics for Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Multiple Outcomes- A Simulation Study and Application

    Nov 1, 2013, 00:00

  • Comparing the Health Care Costs and Utilizations Between Patients with Anxiety Versus Those Without

    Nov 1, 2013, 00:00

  • The Current Management and Costs of Irritable Bowel Syndrome with Constipation in Belgium- A 2-Round Expert Survey

    Nov 1, 2013, 00:00

  • The Use of Data from Published Kaplan-Meier Survival Curves in NICE HTAs

    Nov 1, 2013, 00:00

  • Use of Beta Blocking Agents in Serbia in the Period from 2007 to 2011 Year

    Nov 1, 2013, 00:00

  • Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia- A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation Antipsychotics

    Nov 1, 2013, 00:00

  • A Comparison of the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Diabetes in the United States

    Nov 1, 2013, 00:00

  • Disease Burden in Epilepsy Associated with Tuberous Sclerosis Complex- Systematic Review

    Nov 1, 2013, 00:00

  • Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial

    Nov 1, 2013, 00:00

  • Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment- Results of a Survey Among French Patients

    Nov 1, 2013, 00:00

  • Clinical Effectiveness of Lacosamide and Its Impact on Concomitant Antiepileptic Drugs Consumption in the Czech Republic

    Nov 1, 2013, 00:00

  • Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Antimicrobials as Treatment for Patients with Complicated Skin and Soft Tissues Infections- A Comparison Between Ceftaroline, Linezolid and Vancomycin in the Russian Health Care

    Nov 1, 2013, 00:00

  • Formulations of Amphotericin B for the Treatment of Fungal Infections in Patients with HIV/AIDS

    Nov 1, 2013, 00:00

  • Haemophilia A- Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in Fran We Should Compare the Cost Per Patient Instead of the Price Per Unit

    Nov 1, 2013, 00:00

  • A Systematic Review of Patient Reported Outcomes in Glaucoma

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction

    Nov 1, 2013, 00:00

  • Psoriasis Patients’ Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

    Nov 1, 2013, 00:00

  • Predictor Factors for the Presence of Post Herpetic Neuralgia at 3 Months in Herpes Zoster Patients Aged 50 and Over in Italy- Results from a Gp-Based Observational Prospective Multicenter Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Alendronate Therapy for Secondary Prevention of Osteoporotic Fractures

    Nov 1, 2013, 00:00

  • Reasons Given by the European Medicines Agency for Revising Disease-Specific Scientific Guidelines

    Nov 1, 2013, 00:00

  • Analysis of Brazilian Public Funding Process for New Biologic Drugs

    Nov 1, 2013, 00:00

  • Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis Treatments

    Nov 1, 2013, 00:00

  • Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe- Acesso E Impacto Econômico Em Um Hospital Universitário

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Accepting Submissions with ICERs Higher Than the Threshold

    Nov 1, 2013, 00:00

  • Indirect Treatment Comparison and Economic Evaluation of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in the Netherlands

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable in the United States

    Nov 1, 2013, 00:00

  • Natalizumab for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients- 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Renal Post-Transplant Prophylaxis with Belatacept in Colombia

    Nov 1, 2013, 00:00

  • Biological Agents in the Treatment of Moderate to Severe Psoriasis- A Pharmacoeconomic Analysis

    Nov 1, 2013, 00:00

  • Are the Biotechnology and Pharmaceutical Sectors Defensive Relative to the SP 500?

    Nov 1, 2013, 00:00

  • Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia- Baseline Characteristics of Patients

    Nov 1, 2013, 00:00

  • The Costs of Managing Genital Warts in the UK by Devolved Nation- England, Scotland, Wales and Northern Ireland

    Nov 1, 2013, 00:00

  • Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results of the Rapid ...

    Nov 1, 2013, 00:00

  • Fixed Reference Pricing or Benefit Assessment of Established Products – from the Frying Pan into the Fire?

    Nov 1, 2013, 00:00

  • Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis- What to Do When a Biologic Fails

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of Veteran Patients Diagnosed with Obesity in the United States

    Nov 1, 2013, 00:00

  • The Direct Costs of Drug-Induced Skin Reactions in Poland

    Nov 1, 2013, 00:00

  • Economical Justification of the Innovation Method of Laboratory Diagnostic of the Structural and Functional Changes of Serum Albumin in Septic Complications (Ata-Test)

    Nov 1, 2013, 00:00

  • Dabigatran Etexilate in Prevention of Stroke for Nonvalvular Atrial Fibrillation Patients in Turkish Health Care Setting; A Study on Cost Containment of Social Security Institution (SSI)

    Nov 1, 2013, 00:00

  • Measurements of Adherence to Oral Therapies Among Brazilian Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • The Budget Impact of Qutenza® for the Treatment of Neuropathic Pain in Sweden

    Nov 1, 2013, 00:00

  • A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in Russia

    Nov 1, 2013, 00:00

  • The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an Analgesic

    Nov 1, 2013, 00:00

  • Developing a Publication Strategy in the Context of Outcome Research- A Review of the Literature

    Nov 1, 2013, 00:00

  • Personalized Health Care in France, Germany and the United Kingdom- Are Health Technology Assessment Agencies Ready?

    Nov 1, 2013, 00:00

  • Future Costs Inclusion in Published Economic Evaluations- What Is the Current Situation?

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis in Spain

    Nov 1, 2013, 00:00

  • Investigating the Validity of the UKPDS Outcomes Equations in Current Clinical Practice

    Nov 1, 2013, 00:00

  • Psychometric Properties of the Hypoglycemia Perspectives Questionnaire (HPQ) in Type 2 Diabetes Mellitus

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary Care

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care System

    Nov 1, 2013, 00:00

  • Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

    Nov 1, 2013, 00:00

  • Potential Predictors of Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in German Patients with Schizophrenia

    Nov 1, 2013, 00:00

  • Importance of Subgroup Analyses for Health Technology Assessments

    Nov 1, 2013, 00:00

  • Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates

    Nov 1, 2013, 00:00

  • Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

    Nov 1, 2013, 00:00

  • Unmet Health Needs of Immigrants Living in Greece During the Economic Crisis- The Long-Term Impact for the Health Care System

    Nov 1, 2013, 00:00

  • A Study of A. Baumannii in a Tertiary Care Hospital with Consideration to Risk Factors of Infection and Resistance Pattern

    Nov 1, 2013, 00:00

  • The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation- A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need

    Nov 1, 2013, 00:00

  • Cost of Cancer in the Austrian Hospital Setting

    Nov 1, 2013, 00:00

  • 2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDS

    Nov 1, 2013, 00:00

  • The Importance of Sensitivity Analyses in Health Technology Assessments

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ranibuzumab for the Treatment of Myopic Choroidal Neovascularization in Canada

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Anti-Rabies Prophylaxis After Exposure to Unobservable Dogs in Eradication Context- The French Case

    Nov 1, 2013, 00:00

  • Analysis of Published Health Technology Assessments (HTA) in Russia and Its Place in Russian Reimbursement System

    Nov 1, 2013, 00:00

  • Dealing with Zero Cells in Sparse Networks in Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • How Can Health Economic Assessment Methods Help Decision Making in Portfolio Development

    Nov 1, 2013, 00:00

  • Cost Analysis of Proton Pump Inhibitors in the Treatment of Ulcer Duodenum in Ukraine

    Nov 1, 2013, 00:00

  • Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Continued Improvements in Workplace and Household Productivity with Certolizumab Pegol Treatment in Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 48-Week Results from the Rapid-axSpA ...

    Nov 1, 2013, 00:00

  • How Burdensome Is Completion of Electronic Patient-Reported Outcomes (ePRO)? Item Completion Times and Qualitative Evidence from Studies in Four Different Health Conditions

    Nov 1, 2013, 00:00

  • Projeção De Gastos Com Medicamentos De Uso Crônico (Ambulatorial)

    Nov 1, 2013, 00:00

  • O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No Cérebro

    Nov 1, 2013, 00:00

  • Mood Stabilizers and Atypical Antipsychotics in Maintenance Therapy for Bipolar Disorder- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai

    Nov 1, 2013, 00:00

  • Active-Implantable Cardiac Devices- Is There Room for Cost Savings in Portuguese Hospitals?

    Nov 1, 2013, 00:00

  • Are Conditionally Approved Therapies Successful in Gaining Market Access?

    Nov 1, 2013, 00:00

  • Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Five European Countries

    Nov 1, 2013, 00:00

  • A Systematic Review of Patients’ Treatment Satisfaction and/or Preference Patient-Reported Oucomes Measures Used in Clinical Trials

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Multifocal and Monofocal Intraocular Lenses in Cataract Surgery in the Czech Republic

    Nov 1, 2013, 00:00

  • The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)

    Nov 1, 2013, 00:00

  • Bayesian Evidence Synthesis of Safety Data- A Robust Option?

    Nov 1, 2013, 00:00

  • Using the Delphi Method for Selecting Medical Technologies Under Budget Constraints- A Feasibility Study

    Nov 1, 2013, 00:00

  • Assessing Quality of Life in Adult Growth Hormone Deficiency- Further Development of the QoL-AGHDA

    Nov 1, 2013, 00:00

  • The Impact of Chlamydia and Gonorrhoea Point of Care Nucleic Acid Amplification Tests on Clinical Pathways and Costs in Genito-Urinary Medicine Clinics in the United Kingdom

    Nov 1, 2013, 00:00

  • Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors- The Equade Study

    Nov 1, 2013, 00:00

  • Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

    Nov 1, 2013, 00:00

  • Use of Surrogate Outcomes in Health Technology Assessments (HTAs)

    Nov 1, 2013, 00:00

  • Adherence to Disease-Specific Recommendations for Pharmacoeconomic Studies in Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Costs of Acute Heart Failure in France

    Nov 1, 2013, 00:00

  • Contribution of Latin America to Mental Health in Pregnancy

    Nov 1, 2013, 00:00

  • Breast Cancer Screening Program in the Basque Country- Costs and Health Benefits Assessment Through Discrete Event Simulation

    Nov 1, 2013, 00:00

  • The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment

    Nov 1, 2013, 00:00

  • Cost Utility Analysis of Screening and Treatment of Hyperlipidemia in Chinese Adults Aged 45 and Above

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization Costs Related to Anaemia Management in Chronic Kidney Disease Non-Dialysed Patients- A Retrospective Clinical and Administrative Database Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

    Nov 1, 2013, 00:00

  • The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life

    Nov 1, 2013, 00:00

  • Analysis of Health Care Costs in Elderly Patients with Multiple Chronic Conditions Using a Finite Mixture of Generalized Linear Models

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban Versus Rivaroxaban for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

    Nov 1, 2013, 00:00

  • Economic Evaluation of the Treatment Compliance in Patients with Parkinson’s Disease Received Different Preparations of Levodopa

    Nov 1, 2013, 00:00

  • A Systematic Review on the Effect of Behavioral Versus Surgical Intervention on Obese Patients’ Psychological Well-Being

    Nov 1, 2013, 00:00

  • Health Care Utilization and Expenditures of Osteoporosis Patients Treated with Oral Bisphosphonate in Tianjin, China

    Nov 1, 2013, 00:00

  • Cost of Influenza in Germany

    Nov 1, 2013, 00:00

  • Methodological Challenges in Multi-Criteria Decision Analysis (MCDA) for Health Policy Decision-Making- A Systematic Review

    Nov 1, 2013, 00:00

  • Diabetic Patients in Primary Care- Self-Perception and Satisfaction. Comparative Study Spain Versus Europe

    Nov 1, 2013, 00:00

  • Examining the Relationship Between Country-Level Factors and Vaccine Wastage- A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

    Nov 1, 2013, 00:00

  • Inference on Incremental Cost Effectiveness Thresholds Influencing Nice Decisions- A Bayesian Analysis

    Nov 1, 2013, 00:00

  • Long-Term Survival After Intensive Care Unit Discharge in Thailand- A Retrospective Study

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Del Tratamiento Profiláctico Versus a Demanda En Adolescentes Con Hemofilia a Severa En Colombia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant Patients

    Nov 1, 2013, 00:00

  • Copyright/Subscription

    Nov 1, 2013, 00:00

  • United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Uso De Pruebas Treponémicas Rápidas Para La Detección Y Tratamiento Temprano De Sífilis Gestacional En Colombia

    Nov 1, 2013, 00:00

  • Evaluation of Acute Pancreatitis Signals with Incretin Enhancers- Revisiting Disproportionality Analysis of the Adverse Event Reporting System

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Pulmonary Veins Isolation with Cryo Technique

    Nov 1, 2013, 00:00

  • Burden of Informal Care in Relation to Disease Activity and Disability in Polish Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De Trasplantes

    Nov 1, 2013, 00:00

  • Correlations Between Changes in the Urticaria Activity Score (UAS7) and the Dermatology Life Quality Index (DLQI) from Baseline to 28 or 40 Weeks- Comparisons of Trajectories of Change in Patients with Chronic Spontaneous/Idiopathic Urticar ...

    Nov 1, 2013, 00:00

  • Mortality and Medical Costs Associated with Liver-Related Diseases Among Patients with Hepatitis C Virus(HCV) Infection in Taiwan

    Nov 1, 2013, 00:00

  • Patient-Reported Outcomes- Are They Worth It? An Examination in Pro Value Through Case Studies

    Nov 1, 2013, 00:00

  • Budget Impact of Everolimus for Tuberous Sclerosis Complex (TSC) Related Angiomyolipoma (AML)- United Kingdom Perspective

    Nov 1, 2013, 00:00

  • Usefulness of a Commercial Hospital Claims Database to Identify Current Anti-Vascular Endothelial Growth Factor Treatment Patterns in Patients with Exudative Age-Related Macular Degeneration in Japan

    Nov 1, 2013, 00:00

  • Resource Utilisation and Costs of Total Hip Arthroplasty in the United Kingdom- A Descriptive Analysis

    Nov 1, 2013, 00:00

  • Cost Saving After Sutureless Replacement in Aortic Valve Stenosis- Results from a Propensity-Matched Score Analysis in Germany

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Ivabradine in Chronic Heart Failure in the Polish Setting

    Nov 1, 2013, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Key Design and Operational Considerations for Successful Conduct

    Nov 1, 2013, 00:00

  • The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United States

    Nov 1, 2013, 00:00

  • Localization of Activities and Equivalence of Movement in Clinical Outcomes Assessments

    Nov 1, 2013, 00:00

  • Early-Stage Economic Evaluation of Stratified Medicine in Multiple Myeloma

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France

    Nov 1, 2013, 00:00

  • Modelización Económica Del Genotipado Del Citocromo P450 Con El Test Brainchip En El Tratamiento De La Depresión Mayor

    Nov 1, 2013, 00:00

  • Variations in the Health Status of Irish Regions

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Basiliximab As Induction Therapy for Kidney Transplantation in Mexico

    Nov 1, 2013, 00:00

  • Prevalence and Risk Factors of Actinic Keratoses

    Nov 1, 2013, 00:00

  • Initial Anticoagulation Therapy in Patients with Venous Thromboembolism and Impaired Renal Function- Results of an Observational Study

    Nov 1, 2013, 00:00

  • A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan

    Nov 1, 2013, 00:00

  • Impact of Using Either Multiplicative or Additive Utility Decrements in Decision Models

    Nov 1, 2013, 00:00

  • Patterns in Asthma Medicationtreatment in the United States

    Nov 1, 2013, 00:00

  • Baseline Patient, Ocular Features and Management of a Patient Population Diagnosed with Vitreomacular Traction- An Observational Study in Flanders

    Nov 1, 2013, 00:00

  • Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico- A Comparison to Sweden

    Nov 1, 2013, 00:00

  • The Impact of Generic Substitution on Health Outcomes and Costs- A Systematic Review

    Nov 1, 2013, 00:00

  • Draft Versus Final Guidance in Nice’s Drug Technology Appraisal Process

    Nov 1, 2013, 00:00

  • Efficacy of Fingolimod in Delaying Confirmed Disability Progression in Patients Failing Prior Treatment- A Markov Model Application to Estimate Time to Disability Health States

    Nov 1, 2013, 00:00

  • Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom- A CPRD-Based Study

    Nov 1, 2013, 00:00

  • Social Network Analysis of Authorship Networks and the Identification of Expert Advisors

    Nov 1, 2013, 00:00

  • Health Utilities Index (Hui®)- Population Reference Statistics

    Nov 1, 2013, 00:00

  • Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome

    Nov 1, 2013, 00:00

  • Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • A Health Economic Evaluation of Fenofibric Acid in Combination with Statins in the Prevention of Cardiovascular Disease in Taiwanese Mixed Hyperlipidemia Patients

    Nov 1, 2013, 00:00

  • Models of Drug Safety Monitoring in England, Poland, Italy, Germany, Denmark and United States

    Nov 1, 2013, 00:00

  • A Discrete Choice Experiment to Evaluate Blood Glucose Meter Preferences in People with Type 1 and Type 2 Diabetes in the United Kingdom

    Nov 1, 2013, 00:00

  • Simulating the Potential Impact of Improved Blood Pressure Control on Clinical and Economic Outcomes in Russia

    Nov 1, 2013, 00:00

  • Health Care Resource Usage, Treatment and Costs Among Patients with Hip Fracture in the United Kingdom

    Nov 1, 2013, 00:00

  • Payer and Physicians Evidence and Discount Expectations for Biosimilars in Six Latin American Countries

    Nov 1, 2013, 00:00

  • Utilization of Routine Data for Regionalized Epidemiology in Austria - The Example of Ischemic Heart Disease (ICD9 410-414)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Stribild Compared to Similar Antiretroviral Therapies in a Specialty Retail Pharmacy

    Nov 1, 2013, 00:00

  • Results of Galata Study- Galvus Efficacy and Safety Assessment in Turkish Population

    Nov 1, 2013, 00:00

  • Practice of Cerebroprotectors Consumption in Ukraine

    Nov 1, 2013, 00:00

  • Weight- and Health-Related Quality of Life (WRQoL and HRQoL) with Canagliflozin (CANA) Versus Sitagliptin (SITA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Background Metformin

    Nov 1, 2013, 00:00

  • The Survey of the Japan-Style Premium Scheme in Pharmaceutical Pricing Decisions

    Nov 1, 2013, 00:00

  • Analysis of Public and Private Hospital Databases (PMSI) 2010 / 2011 to Estimate the Frequency and Associated Costs for Febrile Neutropenia in France

    Nov 1, 2013, 00:00

  • Development of a Questionnaire to Evaluate Food-Related Well-Being

    Nov 1, 2013, 00:00

  • Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico

    Nov 1, 2013, 00:00

  • Relationship Between Falls and CNS Drugs at a Acute Care Teaching Hospital in Japan

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Private Health Care System

    Nov 1, 2013, 00:00

  • Health State Utility Values in Advanced Non-Small Cell Lung Cancer Patients

    Nov 1, 2013, 00:00

  • Choosing Health States for Elicitation of Population Preferences for the EQ-5D

    Nov 1, 2013, 00:00

  • Factors Associated with Pain Persistence in Patient with Depression During a 3 –Month Follow-Up Period

    Nov 1, 2013, 00:00

  • Change of Burden of Disease in German Rheumatoid Arthritis Patients Since the Uptake of TNF-Inhibitors- A Literature Review of German Real Life Data

    Nov 1, 2013, 00:00

  • Thyroid Dysfunction Detection in Pregnancy- Universal Screening or Targeted High-Risk Case Finding? A Meta-Analysis

    Nov 1, 2013, 00:00

  • Evaluation of a Process of Care Model for Open Intravesical Ureteral Reimplantation from a Contemporary Health Care Perspective

    Nov 1, 2013, 00:00

  • Paper-Based and Electronic Assessment of Health-Related Quality of Life Specific to HIV Disease- A Reliability Study with the PROQOL-HIV Questionnaire

    Nov 1, 2013, 00:00

  • Comorbidity Influence in the Control of Arterial Hypertension

    Nov 1, 2013, 00:00

  • A Comprehensive Review of Epidemiology and Economic Studies for Patients Diagnosed with Non-Psychotic Major Depressive Disorder

    Nov 1, 2013, 00:00

  • Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer Patients

    Nov 1, 2013, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110 (current)
  • »